CN106072157A - 一种降糖保健食品及其制备方法 - Google Patents
一种降糖保健食品及其制备方法 Download PDFInfo
- Publication number
- CN106072157A CN106072157A CN201610746354.XA CN201610746354A CN106072157A CN 106072157 A CN106072157 A CN 106072157A CN 201610746354 A CN201610746354 A CN 201610746354A CN 106072157 A CN106072157 A CN 106072157A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- semen
- weight
- fructus
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 69
- 239000002253 acid Substances 0.000 claims abstract description 24
- 241000255791 Bombyx Species 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000009337 Spinacia oleracea Nutrition 0.000 claims abstract description 15
- 238000005192 partition Methods 0.000 claims abstract description 15
- 238000000605 extraction Methods 0.000 claims description 65
- 239000000843 powder Substances 0.000 claims description 56
- 239000000706 filtrate Substances 0.000 claims description 15
- 238000010792 warming Methods 0.000 claims description 15
- 241000219315 Spinacia Species 0.000 claims description 14
- 239000000052 vinegar Substances 0.000 claims description 13
- 235000021419 vinegar Nutrition 0.000 claims description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 10
- 102000002322 Egg Proteins Human genes 0.000 claims description 10
- 108010000912 Egg Proteins Proteins 0.000 claims description 10
- 240000007594 Oryza sativa Species 0.000 claims description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 210000003278 egg shell Anatomy 0.000 claims description 10
- 239000012535 impurity Substances 0.000 claims description 10
- 230000010355 oscillation Effects 0.000 claims description 10
- 235000009566 rice Nutrition 0.000 claims description 10
- 238000000638 solvent extraction Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
- 239000001569 carbon dioxide Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000005538 encapsulation Methods 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 241000255789 Bombyx mori Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 201000001421 hyperglycemia Diseases 0.000 abstract description 8
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 230000010354 integration Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 244000300264 Spinacia oleracea Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 230000000378 dietary effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 235000000832 Ayote Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000205754 Colocasia esculenta Species 0.000 description 2
- 235000006481 Colocasia esculenta Nutrition 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 241000934136 Verruca Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000015136 pumpkin Nutrition 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000003890 Coronary Vasospasm Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000002115 aflatoxin B1 Substances 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 229930020125 aflatoxin-B1 Natural products 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000011634 coronary artery vasospasm Diseases 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008660 qian-zheng-san Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种降糖保健食品及其制备方法,由以下重量配比的原料制成:苦瓜20‑45重量份、洋葱10‑15重量份、南瓜20‑45重量份、薏苡仁5‑10重量份、炒莱菔子3‑6重量份、山药20‑45重量份、芋头20‑45重量份、番石榴叶5‑10重量份、马齿苋5‑10重量份、僵蚕散3‑8重量份、胡桃分心木3‑8重量份、荔枝核3‑8重量份、菠菜根6‑12重量份、干玉米须6‑12重量份、柳枝叶5‑10重量份、醋蛋粉10‑15重量份、黑豆15‑30重量份。本发明采用多种药食同源的食物,可以长期食用,能够同时预防和治疗高血糖,治疗效果较好,见效快,副作用小。
Description
技术领域
本发明涉及一种降糖保健食品及其制备方法。
背景技术
当血糖值高过规定的水平时就会形成高血糖症。它可能历时数日或在几个小时内即能形成。正常人在清晨空腹血糖浓度为80~120毫克%。空腹血糖浓度超过130毫克%称为高血糖。如果血糖浓度超进160~180毫克%,就有一部分葡萄糖随尿排出,这就是糖尿。血糖浓度低于70毫克%称为低血糖。高血糖也是通常大家所说“三高”中的一高。另外“两高”分别是高血压和高甘油三酯。食疗是中国人的传统习惯,通过饮食达到调理身体,强壮体魄的目的。食疗文化源远流长,食疗是一种长远的养生行为。以前的人通过食疗调理身体,现在的人通过食疗减肥、护肤、护发。食疗是一种健康的健体之道。
保健食品是食品的一个种类,具有一般食品的共性,能调节人体的机能,适于特定人群食用,但不能治疗疾病。保健食品在欧美各国被称为“健康食品”,在日本被称为“功能食品”。我国保健食品的兴起是在20 世纪80 年代末90 年代初,经过一、二代的发展,也将迈入第三代,即保健食品不仅需要人体及动物实验证明该产品具有某项生理调节功能,更需查明具有该项保健功能因子的结构、含量、作用机理以及在食品中应有的稳定形态,目前的保健食品办降血糖作用不明显,原材料种类稀少、价格昂贵。
发明内容
针对上述现有技术存在的问题,本发明提供了一种降糖保健食品及其制备方法,采用多种药食同源的食物,可以长期食用,能够同时预防和治疗高血糖,治疗效果较好,见效快,副作用小。
为了实现上述目的,本发明采用的技术方案是:
一种降糖保健食品,由以下重量配比的原料制成:苦瓜20-45重量份、洋葱10-15重量份、南瓜20-45重量份、薏苡仁5-10重量份、炒莱菔子3-6重量份、山药20-45重量份、芋头20-45重量份、番石榴叶5-10重量份、马齿苋5-10重量份、僵蚕散3-8重量份、胡桃分心木3-8重量份、荔枝核3-8重量份、菠菜根6-12重量份、干玉米须6-12重量份、柳枝叶5-10重量份、醋蛋粉10-15重量份、黑豆15-30重量份。
上述任一方案优选的是,由以下重量配比的原料制成:苦瓜30-40重量份、洋葱12-14重量份、南瓜30-40重量份、薏苡仁6-8重量份、炒莱菔子4-5重量份、山药30-40重量份、芋头30-40重量份、番石榴叶6-8重量份、马齿苋6-8重量份、僵蚕散4-6重量份、胡桃分心木4-6重量份、荔枝核4-6重量份、菠菜根8-10重量份、干玉米须8-10重量份、柳枝叶6-8重量份、醋蛋粉12-14重量份、黑豆20-25重量份。
上述任一方案优选的是,,由以下重量配比的原料制成:苦瓜35重量份、洋葱13重量份、南瓜35重量份、薏苡仁7重量份、莱菔4.5重量份、山药35重量份、芋头35重量份、番石榴叶7重量份、马齿苋7重量份、僵蚕散5重量份、胡桃分心木5重量份、荔枝核5重量份、菠菜根9重量份、干玉米须9重量份、柳枝叶7重量份、醋蛋粉13重量份、黑豆23重量份。
本发明还公开一种降糖保健食品的制备方法,包括以下步骤:
步骤(1).按照重量比取苦瓜、洋葱、南瓜、薏苡仁、山药、芋头除杂后洗净、蒸熟、烘干,粉碎至60 目-100目,得到粉末A;
步骤(2).取僵蚕散研成细末,得到粉末B;
步骤(3).按照重量比取炒莱菔子、番石榴叶、马齿苋、胡桃分心木、荔枝核、菠菜根、干玉米须、柳枝叶,除杂、洗净、烘干,粉碎至60-80 目, 得到粉末C;
步骤(4).将粉末C搅匀放入浸提罐内,向浸提罐内加入6-8 倍量的水形成原料水溶液,梯度升温萃取,然后过滤萃取后的溶液形成滤液,取该滤液备用;
步骤(5).将步骤(4)得到的滤液浓缩、干燥后粉碎成粉末D;
步骤(6).取黑豆,洗净晾干,放入清洁干燥的广口玻璃瓶内,倒入2倍量的无糖九度米醋,盖好盖子,放置于阴凉处,一个月后捞出黑豆,烘干,磨碎成粉末E;
步骤(7).醋蛋粉的泡制方法:取新鲜鸡蛋,洗净外皮,拭干水分,放入玻璃瓶中,倒入无糖九度米醋至液面能够淹没鸡蛋,36小时后蛋壳变软,用筷子挑破蛋壳,搅匀,即成醋蛋液,将醋蛋液浓缩、干燥粉碎既成醋蛋粉;
步骤(8).将粉末A、粉末B、粉末C、粉末D、粉末E和醋蛋粉混合均匀后灭菌、封装。
优选的是,所述步骤(4)中的梯度升温萃取的方法为,初次升温至50℃进行超声振荡浸提萃取,浸提萃取时间为10-20分钟;再升温至70℃进行超声振荡浸提萃取,浸提萃取时间为20-30分钟;最后升温至90℃进行超声振荡浸提萃取,浸提萃取时间为30-40 分钟。
本发明的原料
苦瓜:清热消暑、养血益气、补肾健脾、滋肝明目的功效,对治疗痢疾、疮肿、中暑发热、痱子过多、结膜炎等病有一定的功效。苦瓜具有预防坏血病、保护细胞膜、防止动脉粥样硬化、提高机体应激能力、保护心脏等作用。苦瓜中的有效成分可以抑制正常细胞的癌变和促进突变细胞的复原,具有一定的抗癌作用。具有降血糖、降血脂、抗肿瘤、预防骨质疏松、调节内分泌、抗氧化、抗菌以及提高人体免疫力等药用和保健功能。美容肌肤苦瓜能滋润白皙皮肤,还能镇静和保湿肌肤,特别是在容易燥热的夏天,敷上冰过的苦瓜片,能立即解除肌肤的烦躁。
干玉米须:利尿,泄热,平肝,利胆。治肾炎水肿,脚气,黄疸肝炎,高血压,高血糖,胆囊炎,胆结石,糖尿病,吐血衄血,鼻渊,乳痈。宽肠下气。治妇人乳结,乳汁不通,红肿疼痛,怕冷发热,头痛体困。为利尿药,对肾脏病、浮肿性疾患、糖尿病等有效。又为胆囊炎、胆石、肝炎性黄疸等的有效药。能降低血压,利尿消肿。治鼻血、红崩。
马齿苋,性寒,味甘酸;入心、肝、脾、大肠经。含有大量蛋白质、脂肪、糖、粗纤维及钙、磷、铁等多种营养成分,并且富含去甲肾上腺素和钾盐,能促进胰岛素分泌,调节人体内糖的代谢,具有降低血糖浓度、保持血糖稳定的作用;可降低血压,降血糖、减慢心率,具有保护心脏的作用。马齿苋还含有大量维生素E、维生素C、胡萝卜素及谷胱甘肽等抗衰老有效成分,长期食用能预防血小板凝聚、冠状动脉痉挛和血栓形成,从而有效地防止冠心病。此外,对痢疾杆菌、大肠杆菌、金黄色葡萄球菌等多种细菌都有强效抑制作用,有“天然抗生素”的美称。
洋葱,几乎不含脂肪,而在其精油中含有可以降低胆固醇的含硫化物的混合物。洋葱是目前所知道的唯一含前列腺素的植物,还含有能激活血溶纤维蛋白活性的成分。这些物质均为较强的血管舒张剂,能减少外周血管和心脏冠状动脉的阻力,对抗人体内儿茶酚胺等升压物质的作用,又能促进钠盐的排泄,从而使血压下降。可以说,洋葱是高血脂、高血压、高血糖等心血管病人的佳蔬良药。
炒莱菔子含有丰富的油脂,油脂有养阴益气、润肠通便之功能。所以,民间有不少以炒莱菔子为主的通便验方。
南瓜,别名番瓜、倭瓜,属葫芦科植物。中医认为南瓜性温、味甘、具有补中益气、健脾暖胃、消炎止痛、解毒杀虫之功效。南瓜营养丰富,含有丰富的瓜氨酸、精氨酸、天门冬酸、多种不饱和脂肪酸以及葫芦巴碱、腺嘌呤、胡萝卜素、葡萄糖、蔗粮、戊聚糖、甘露醇及大量的维生素B、C和E及多种微量元素如镁、铁、铜、硒、锌等。南瓜能促进人体胰岛素的分泌及增强肝肾细胞的再生能力,因此,可以有效地防治糖尿病、高血压和一些肝肾疾病。
薏苡仁:利湿健脾;舒筋除痹;清热排脓。主水肿;脚气;小便淋沥;湿温病;泄泻带下;风湿痹痛;筋脉拘挛;肺痈;肠痈;扁平疣。用于水肿,脚气,小便不利,湿痹拘挛,脾虚泄泻,肺痈,肠痈;扁平疣。
山药:补脾;养肺;固肾;益精。主脾虚泄泻;食少浮肿;肺虚咳喘;消渴;遗精;带下;肾虚尿频;外用治痈肿;瘰疬。用于脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,适用于高血糖患者食用。
芋头:益脾胃,调中下气,清热解毒,软坚散结;久服有补中益肝肾,添精益髓,疗热止渴的功用。生芋内服能治淋巴结肿大,外用可消炎、消肿、镇痛。适用于瘰疬、肿毒、腹中癖块、虫咬蜂螫、乳腺炎、大便干结、甲状腺肿大、急性关节炎、产后恶露排出不畅等病症。
番石榴叶,为桃金娘科植物番石榴的干燥叶及带叶嫩茎,在民间传统具有健胃消食、涩肠止泻、杀虫止痒、收敛止血的作用。近年来研究发现,它还具有很好的降糖、降脂作用,对黄曲霉素B1所致的大鼠肝癌具有较强的抑制效果,具有广阔的开发前景。
僵蚕散,熄风止痉,祛风止痛,化痰散结。僵蚕熄肝风止痉挛抽搐,且兼可化痰,故用于惊痫抽搐诸证。僵蚕味辛行散,又能祛外风止痉挛抽搐,常用于风中经络之口眼斜,通常与全蝎、白附子等同用,方如牵正散;根据僵蚕祛外风,散风热,止痛、止痒之功,也用于风热头痛、目赤、咽痛及风疹瘙痒,治肝经风热上攻之头痛、目赤肿痛、迎风流泪,常与桑叶、木贼、荆芥等疏风清热药配伍,方如白僵蚕散;用治风热上攻之咽喉肿痛、声音嘶哑者,可与桔梗、荆芥、甘草等同用,方如六味汤;治风疹瘙痒可单用研末服,或与蝉蜕、薄荷等祛风止痒药同用。此外僵蚕味咸,能软坚散结,又兼可化痰,还常与浙贝母、夏枯草、连翘等清热化痰散结药物同用,以治疗痰核、瘰疬。
胡桃分心木,有健脾固肾、利尿清热、淋病尿血,暑热泻痢、崩中下血,治遗溺、耳聋、遗尿的功能。
荔枝核,理气止痛;祛寒散滞。主疝气痛;睾丸肿痛;胃脘痛;痛经及产后腹痛。用于寒疝腹痛,睾丸肿痛,可与降血糖药物同用。
菠菜根,解热毒、酒毒,清热除烦,利五脏,通血脉,下气调中,止渴,润肠。适用于贫血、便血、慢性便秘、小便不畅、高血压、糖尿病、肺结核、痔疾、醉酒、夜盲症、跌打损伤等病症;并能助消化。尤可预防便秘、高血压、糖尿病。
柳枝叶,它含有丰富的鞣质,有清热解毒、利湿消肿之功。水煎服可治疗上呼吸道感染、支气管炎、肺炎、膀胱炎、腮腺炎、咽喉炎。捣烂外敷,可治疗足跟疼痛。有明显的降血糖作用,其作用机制有可能是通过恢复病变胰岛细胞的结构与功能,也可能是增加外周组织的胰岛素受体或提高受体敏感性。
醋蛋液,可以降血脂,降血糖,增强机体抗自由基的作用,对预防动脉硬化有帮助,也有一定的通便、降低体重、提高免疫和抗疲劳作用,醋有助消化、消食滞的作用,可以帮助人吸收食物中的营养成分,起到强身祛病的效果;鸡蛋中则含有丰富的蛋白质和卵磷脂。
黑豆,养肾、补肾。对于高血压和高血糖患者有显著的疗效。
本发明的有益效果是:本发明采用多种药食同源的食物,可以长期食用,能够同时预防和治疗高血糖,治疗效果较好,见效快,副作用小。
具体实施方式
实施例1
本发明公开一种降糖保健食品,由以下重量配比的原料制成:苦瓜20重量份、洋葱10重量份、南瓜20重量份、薏苡仁5重量份、炒莱菔子3重量份、山药20重量份、芋头20重量份、番石榴叶5重量份、马齿苋5重量份、僵蚕散3重量份、胡桃分心木3重量份、荔枝核3重量份、菠菜根6重量份、干玉米须6重量份、柳枝叶5重量份、醋蛋粉10重量份、黑豆15重量份。
降糖保健食品的制备方法包括以下步骤:
步骤(1).按照重量比取苦瓜、洋葱、南瓜、薏苡仁、山药、芋头除杂后洗净、蒸熟、烘干,粉碎至60 目,得到粉末A;
步骤(2).取僵蚕散研成细末,得到粉末B;
步骤(3).按照重量比取炒莱菔子、番石榴叶、马齿苋、胡桃分心木、荔枝核、菠菜根、干玉米须、柳枝叶,除杂、洗净、烘干,粉碎至60目, 得到粉末C;
步骤(4).将粉末C搅匀放入浸提罐内,向浸提罐内加入6倍量的水形成原料水溶液,梯度升温萃取,然后过滤萃取后的溶液形成滤液,取该滤液备用;梯度升温萃取的方法为,初次升温至50℃进行超声振荡浸提萃取,浸提萃取时间为10分钟;再升温至70℃进行超声振荡浸提萃取,浸提萃取时间为20分钟;最后升温至90℃进行超声振荡浸提萃取,浸提萃取时间为30分钟。
步骤(5).将步骤(4)得到的滤液浓缩、干燥后粉碎成粉末D;
步骤(6).取黑豆,洗净晾干,放入清洁干燥的广口玻璃瓶内,倒入2倍量的无糖九度米醋,盖好盖子,放置于阴凉处,一个月后捞出黑豆,烘干,磨碎成粉末E;
步骤(7).醋蛋粉的泡制方法:取新鲜鸡蛋,洗净外皮,拭干水分,放入玻璃瓶中,倒入无糖九度米醋至液面能够淹没鸡蛋,36小时后蛋壳变软,用筷子挑破蛋壳,搅匀,即成醋蛋液,将醋蛋液浓缩、干燥粉碎既成醋蛋粉;
步骤(8).将粉末A、粉末B、粉末C、粉末D、粉末E和醋蛋粉混合均匀后灭菌、封装。
实施例2
一种降糖保健食品,由以下重量配比的原料制成:苦瓜45重量份、洋葱15重量份、南瓜45重量份、薏苡仁10重量份、炒莱菔子6重量份、山药45重量份、芋头45重量份、番石榴叶10重量份、马齿苋10重量份、僵蚕散8重量份、胡桃分心木8重量份、荔枝核8重量份、菠菜根12重量份、干玉米须12重量份、柳枝叶10重量份、醋蛋粉15重量份、黑豆30重量份。
降糖保健食品制备方法,包括以下步骤:
步骤(1).按照重量比取苦瓜、洋葱、南瓜、薏苡仁、山药、芋头除杂后洗净、蒸熟、烘干,粉碎至100目,得到粉末A;
步骤(2).取僵蚕散研成细末,得到粉末B;
步骤(3).按照重量比取炒莱菔子、番石榴叶、马齿苋、胡桃分心木、荔枝核、菠菜根、干玉米须、柳枝叶,除杂、洗净、烘干,粉碎至80 目, 得到粉末C;
步骤(4).将粉末C搅匀放入浸提罐内,向浸提罐内加入8 倍量的水形成原料水溶液,梯度升温萃取,然后过滤萃取后的溶液形成滤液,取该滤液备用;梯度升温萃取的方法为,初次升温至50℃进行超声振荡浸提萃取,浸提萃取时间为20分钟;再升温至70℃进行超声振荡浸提萃取,浸提萃取时间为30分钟;最后升温至90℃进行超声振荡浸提萃取,浸提萃取时间为40 分钟。
步骤(5).将步骤(4)得到的滤液浓缩、干燥后粉碎成粉末D;
步骤(6).取黑豆,洗净晾干,放入清洁干燥的广口玻璃瓶内,倒入2倍量的无糖九度米醋,盖好盖子,放置于阴凉处,一个月后捞出黑豆,烘干,磨碎成粉末E;
步骤(7).醋蛋粉的泡制方法:取新鲜鸡蛋,洗净外皮,拭干水分,放入玻璃瓶中,倒入无糖九度米醋至液面能够淹没鸡蛋,36小时后蛋壳变软,用筷子挑破蛋壳,搅匀,即成醋蛋液,将醋蛋液浓缩、干燥粉碎既成醋蛋粉;
步骤(8).将粉末A、粉末B、粉末C、粉末D、粉末E和醋蛋粉混合均匀后灭菌、封装。
实施例3
一种降糖保健食品,由以下重量配比的原料制成:苦瓜35重量份、洋葱13重量份、南瓜35重量份、薏苡仁7重量份、炒莱菔子4.5重量份、山药35重量份、芋头35重量份、番石榴叶7重量份、马齿苋7重量份、僵蚕散5重量份、胡桃分心木5重量份、荔枝核5重量份、菠菜根9重量份、干玉米须9重量份、柳枝叶7重量份、醋蛋粉13重量份、黑豆23重量份。
降糖保健食品的制备方法,包括以下步骤:
步骤(1).按照重量比取苦瓜、洋葱、南瓜、薏苡仁、山药、芋头除杂后洗净、蒸熟、烘干,粉碎至80目,得到粉末A;
步骤(2).取僵蚕散研成细末,得到粉末B;
步骤(3).按照重量比取炒莱菔子、番石榴叶、马齿苋、胡桃分心木、荔枝核、菠菜根、干玉米须、柳枝叶,除杂、洗净、烘干,粉碎至70 目, 得到粉末C;
步骤(4).将粉末C搅匀放入浸提罐内,向浸提罐内加入7 倍量的水形成原料水溶液,梯度升温萃取,然后过滤萃取后的溶液形成滤液,取该滤液备用;梯度升温萃取的方法为,初次升温至50℃进行超声振荡浸提萃取,浸提萃取时间为15分钟;再升温至70℃进行超声振荡浸提萃取,浸提萃取时间为25分钟;最后升温至90℃进行超声振荡浸提萃取,浸提萃取时间为35 分钟。
步骤(5).将步骤(4)得到的滤液浓缩、干燥后粉碎成粉末D;
步骤(6).取黑豆,洗净晾干,放入清洁干燥的广口玻璃瓶内,倒入2倍量的无糖九度米醋,盖好盖子,放置于阴凉处,一个月后捞出黑豆,烘干,磨碎成粉末E;
步骤(7).醋蛋粉的泡制方法:取新鲜鸡蛋,洗净外皮,拭干水分,放入玻璃瓶中,倒入无糖九度米醋至液面能够淹没鸡蛋,36小时后蛋壳变软,用筷子挑破蛋壳,搅匀,即成醋蛋液,将醋蛋液浓缩、干燥粉碎既成醋蛋粉;
步骤(8).将粉末A、粉末B、粉末C、粉末D、粉末E和醋蛋粉混合均匀后灭菌、封装。
本发明的降糖保健食品,可以用开水冲调成糊,进行食用。本发明由于味道较好,也可以作为常规食品食用。
对本发明实施例所提供的技术方案进行了详细介绍,本文中应用了具体个例对本发明实施例的原理以及实施方式进行了阐述,以上实施例的说明只适用于帮助理解本发明实施例的原理;同时,对于本领域的一般技术人员,依据本发明实施例,在具体实施方式以及应用范围上均会有改变之处,综上所述,本说明书内容不应理解为对本发明的限制。
Claims (5)
1.一种降糖保健食品,其特征在于,由以下重量配比的原料制成:苦瓜20-45重量份、洋葱10-15重量份、南瓜20-45重量份、薏苡仁5-10重量份、炒莱菔子3-6重量份、山药20-45重量份、芋头20-45重量份、番石榴叶5-10重量份、马齿苋5-10重量份、僵蚕散3-8重量份、胡桃分心木3-8重量份、荔枝核3-8重量份、菠菜根6-12重量份、干玉米须6-12重量份、柳枝叶5-10重量份、醋蛋粉10-15重量份、黑豆15-30重量份。
2.根据权利要求1所述的一种降糖保健食品,其特征在于,由以下重量配比的原料制成:苦瓜30-40重量份、洋葱12-14重量份、南瓜30-40重量份、薏苡仁6-8重量份、炒莱菔子4-5重量份、山药30-40重量份、芋头30-40重量份、番石榴叶6-8重量份、马齿苋6-8重量份、僵蚕散4-6重量份、胡桃分心木4-6重量份、荔枝核4-6重量份、菠菜根8-10重量份、干玉米须8-10重量份、柳枝叶6-8重量份、醋蛋粉12-14重量份、黑豆20-25重量份。
3.根据权利要求1所述的一种降糖保健食品,其特征在于,由以下重量配比的原料制成:苦瓜35重量份、洋葱13重量份、南瓜35重量份、薏苡仁7重量份、炒莱菔子4.5重量份、山药35重量份、芋头35重量份、番石榴叶7重量份、马齿苋7重量份、僵蚕散5重量份、胡桃分心木5重量份、荔枝核5重量份、菠菜根9重量份、干玉米须9重量份、柳枝叶7重量份、醋蛋粉13重量份、黑豆23重量份。
4.根据上述任意一项权利要求所述的降糖保健食品,其特征在于,制备方法包括以下步骤:
步骤(1).按照重量比取苦瓜、洋葱、南瓜、薏苡仁、山药、芋头除杂后洗净、蒸熟、烘干,粉碎至60 目-100目,得到粉末A;
步骤(2).取僵蚕散研成细末,得到粉末B;
步骤(3).按照重量比取炒莱菔子、番石榴叶、马齿苋、胡桃分心木、荔枝核、菠菜根、干玉米须、柳枝叶,除杂、洗净、烘干,粉碎至60-80 目, 得到粉末C;
步骤(4).将粉末C搅匀放入浸提罐内,向浸提罐内加入6-8 倍量的水形成原料水溶液,梯度升温萃取,然后过滤萃取后的溶液形成滤液,取该滤液备用;
步骤(5).将步骤(4)得到的滤液浓缩、干燥后粉碎成粉末D;
步骤(6).取黑豆,洗净晾干,放入清洁干燥的广口玻璃瓶内,倒入2倍量的无糖九度米醋,盖好盖子,放置于阴凉处,一个月后捞出黑豆,烘干,磨碎成粉末E;
步骤(7).醋蛋粉的泡制方法:取新鲜鸡蛋,洗净外皮,拭干水分,放入玻璃瓶中,倒入无糖九度米醋至液面能够淹没鸡蛋,36小时后蛋壳变软,用筷子挑破蛋壳,搅匀,即成醋蛋液,将醋蛋液浓缩、干燥粉碎既成醋蛋粉;
步骤(8).将粉末A、粉末B、粉末C、粉末D、粉末E和醋蛋粉混合均匀后灭菌、封装。
5.根据权利要求4所述的一种降糖保健食品,其特征在于,所述步骤(4)中的梯度升温萃取的方法为,初次升温至50℃进行超声振荡浸提萃取,浸提萃取时间为10-20分钟;再升温至70℃进行超声振荡浸提萃取,浸提萃取时间为20-30分钟;最后升温至90℃进行超声振荡浸提萃取,浸提萃取时间为30-40 分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610746354.XA CN106072157A (zh) | 2016-08-29 | 2016-08-29 | 一种降糖保健食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610746354.XA CN106072157A (zh) | 2016-08-29 | 2016-08-29 | 一种降糖保健食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106072157A true CN106072157A (zh) | 2016-11-09 |
Family
ID=57223949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610746354.XA Pending CN106072157A (zh) | 2016-08-29 | 2016-08-29 | 一种降糖保健食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106072157A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107148984A (zh) * | 2017-06-29 | 2017-09-12 | 华南理工大学 | 一种抗氧化番石榴叶营养餐条及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189418A (zh) * | 2014-09-01 | 2014-12-10 | 梁成 | 一种降血糖血压的洋葱制剂及其制备方法 |
CN104306655A (zh) * | 2014-10-15 | 2015-01-28 | 陶娅娜 | 一种降血压血糖血脂的蔬菜制剂及其制备方法 |
CN104940665A (zh) * | 2014-03-28 | 2015-09-30 | 李学禹 | 治疗糖尿病的药液 |
-
2016
- 2016-08-29 CN CN201610746354.XA patent/CN106072157A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104940665A (zh) * | 2014-03-28 | 2015-09-30 | 李学禹 | 治疗糖尿病的药液 |
CN104189418A (zh) * | 2014-09-01 | 2014-12-10 | 梁成 | 一种降血糖血压的洋葱制剂及其制备方法 |
CN104306655A (zh) * | 2014-10-15 | 2015-01-28 | 陶娅娜 | 一种降血压血糖血脂的蔬菜制剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
关玉峰: "《名医和你谈健康糖尿病防治随身书》", 30 April 2014, 辽宁科学技术出版社 * |
王英等: "《糖尿病人的饮食管理》", 31 October 2014, 知识产权出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107148984A (zh) * | 2017-06-29 | 2017-09-12 | 华南理工大学 | 一种抗氧化番石榴叶营养餐条及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102511869B (zh) | 红枣生姜浓浆 | |
CN106212338A (zh) | 一种河虾的环保养殖方法 | |
CN106399030A (zh) | 一种保健荔枝甜酒及其制备方法 | |
CN105901715A (zh) | 一种鹿胶糕及其制备方法 | |
CN101167992A (zh) | 一种平衡减肥和全面防治感冒和糖尿病及美容的凉爽保健啤酒 | |
CN103610153A (zh) | 一种健脾养生汤及其制作方法 | |
CN101946895B (zh) | 一种以泥鳅为主料的功能食品及其制备方法 | |
CN104825874A (zh) | 有助于尿酸代谢的傣族食品及其制备方法 | |
US10485834B2 (en) | Chinese herbal oral paste for conditioning phlegm-dampness constitution and processing method thereof | |
CN106071692A (zh) | 一种石斛制品以及用途 | |
CN105851365A (zh) | 玉米须决明子代用茶及其制作方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
CN106070783A (zh) | 一种薏米祛湿茶的生产工艺 | |
CN106072157A (zh) | 一种降糖保健食品及其制备方法 | |
CN107114507A (zh) | 一种具有益生元组合物奶茶及其制备方法 | |
CN103301357A (zh) | 一种促进乌发中药制剂的配方及制备方法 | |
CN107114520A (zh) | 一种益生元奶茶及其制备方法 | |
CN103734609B (zh) | 增强心脑供血,供氧,健脾补气,养血补肾药食同膳面 | |
CN106421519A (zh) | 一种保健药酒 | |
CN105454750A (zh) | 一种芝麻蜂蜜糖浆的制备方法 | |
CN106343092A (zh) | 一种养肝益精茶凉茶饮料及其制备方法 | |
CN106106906A (zh) | 一种核桃红茶凉茶饮料及其制备方法 | |
CN104998131A (zh) | 可用于促进伤骨愈合的组合物及其制备方法 | |
CN105919098A (zh) | 一种用于治疗高血压和慢性便秘的保健品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
RJ01 | Rejection of invention patent application after publication |